Skip to search boxSkip to navigationSkip to main content

Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke

  • Kathleen M. Buckley
    ,
  • Daniel L. Hess
    ,
  • Irina Y. Sazonova
    ,
  • Sudharsan Periyasamy-Thandavan
    ,
  • ,
  • Russell Kirks
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Background and purpose: The role of autophagy in response to ischemic stroke has been confusing with reports that both enhancement and inhibition of autophagy decrease infarct size and improve post-stroke outcomes. We sought to clarify this by comparing pharmacologic modulation of autophagy in two clinically relevant murine models of stroke.Methods: We used rapamycin to induce autophagy, and chloroquine to block completion of autophagy, by treating mice immediately after stroke and at 24 hours post-stroke in two different models; permanent Middle Cerebral Artery Ligation (MCAL), which does not allow for reperfusion of distal trunk of middle cerebral artery, and Embolic Clot Middle Cerebral Artery Occlusion (eMCAO) which allows for a slow reperfusion similar to that seen in most human stroke patients. Outcome measures at 48 hours post-stroke included infarct size analysis, behavioral assessment using Bederson neurological scoring, and survival.Results: Chloroquine treatment reduced the lesion size by approximately 30% and was significant only in the eMCAO model, where it also improved the neurological score, but did not increase survival. Rapamycin reduced lesion size by 44% and 50% in the MCAL and eMCAO models, respectively. Rapamycin also improved the neurological score to a greater degree than chloroquine and improved survival.Conclusions: While both inhibition and enhancement of autophagy by pharmacological intervention decreased lesion size and improved neurological scores, the enhancement with rapamycin showed a greater degree of improvement in outcomes as well as in survival. The protective action seen with chloroquine may be in part due to off-target effects on apoptosis separate from blocking lysosomal activity in autophagy. We conclude pharmacologic induction of autophagy is more advantageous than its blockade in physiologically-relevant permanent and slow reperfusion stroke models.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

8

Journal (Volume, Issue Number)

Experimental and Translational Stroke Medicine (Volume 6, Issue 1)

Publication milestones

  • Published - 06/21/2014

Publication status

Published - 06/21/2014

ISSN

2040-7378

Publication IDs

  • Scopus: 84902722491

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
2.25
SciVal
Author count
13
SciVal
citations
59
SciVal
Paper percentile
95
SciVal
Top percentile
5
Fractional count
8
Fractional count
0.62
Fractional count
5
Fractional count
0.38
Fractional count
8
Fractional count
1

PlumX, opens in new tab

Captures
40
Citation count
85

Funding Details

The authors thank Marina A Zemskova for her help with TTC analysis. This publication is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development with VA Merit Award 104462 (WDH), by the National Institutes of Health with NIA-AG036675-01 (WDH), R21NS081143 (DCH), R21-NS072318 (IYS), and by the American Legion Department of Georgia (WDH). This work was also partially supported by GRU start-up funds (MNH and IYS). The contents of this publication do not represent the views of the Department of Veterans Affairs, or the United States Government.
FundersFunding numbers
American Legion Department of Georgia
-
NIH
NIA-AG036675-0, R21-NS072318, R21NS081143, NIA-AG036675-01
ORD
104462
WDH
-
VA
-
HSR&D
-
GRU
-